272 related articles for article (PubMed ID: 26875157)
1. Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.
Casey MJ; Colanta AB
Fam Cancer; 2016 Jul; 15(3):371-84. PubMed ID: 26875157
[TBL] [Abstract][Full Text] [Related]
2. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
Casey MJ; Bewtra C
Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
Shaw PA; Clarke BA
Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
[TBL] [Abstract][Full Text] [Related]
5. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and Treatment of HBOC Syndrome by a Breast Surgical Oncologist].
Kida K; Murai M; Yamauchi H
Gan To Kagaku Ryoho; 2017 Feb; 44(2):111-115. PubMed ID: 28223669
[TBL] [Abstract][Full Text] [Related]
7. Surgical Management of Hereditary Breast Cancer.
Berger ER; Golshan M
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573353
[TBL] [Abstract][Full Text] [Related]
8. Re: "Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations".
Olivier RI; van Beurden M
Gynecol Oncol; 2005 Nov; 99(2):520-1. PubMed ID: 16188301
[No Abstract] [Full Text] [Related]
9. [Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries].
Menkiszak J; Chudecka-Głaz A; Gronwald J; Bedner R; Cymbaluk-Płoska A; Wezowska M; Zielińska D; Rzepka-Górska I
Ginekol Pol; 2013 Sep; 84(9):758-64. PubMed ID: 24191513
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
Carcangiu ML; Peissel B; Pasini B; Spatti G; Radice P; Manoukian S
Am J Surg Pathol; 2006 Oct; 30(10):1222-30. PubMed ID: 17001151
[TBL] [Abstract][Full Text] [Related]
12. What about prophylactic surgery in BRCA1/BRCA2 mutation carriers? Observations from an Italian pilot study.
Dionigi F; Maffoni M; Ferrari A; Garcia-Etienne CA; Ricciardi A; Razzaboni E; Sgarella A; Trotti E
Breast J; 2017 Nov; 23(6):766-767. PubMed ID: 28574632
[No Abstract] [Full Text] [Related]
13. Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2.
Hoang LN; Gilks BC
Adv Anat Pathol; 2018 Mar; 25(2):85-95. PubMed ID: 28914618
[TBL] [Abstract][Full Text] [Related]
14. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
[TBL] [Abstract][Full Text] [Related]
15. Risk-reducing salpingectomy: Let us be opportunistic.
Long Roche KC; Abu-Rustum NR; Nourmoussavi M; Zivanovic O
Cancer; 2017 May; 123(10):1714-1720. PubMed ID: 28334425
[TBL] [Abstract][Full Text] [Related]
16. [Genetical aspects of surgical treatment in patients with hereditary breast cancer].
Bit-Sava EM
Vestn Khir Im I I Grek; 2014; 173(5):27-30. PubMed ID: 25823331
[TBL] [Abstract][Full Text] [Related]
17. A model for estimating ovarian cancer risk: application for preventive oophorectomy.
Giannakeas V; Sopik V; Shestopaloff K; Iqbal J; Rosen B; Akbari M; Narod SA
Gynecol Oncol; 2015 Nov; 139(2):242-7. PubMed ID: 26341709
[TBL] [Abstract][Full Text] [Related]
18. [Molecular Diagnosis and Treatment of HBOC Syndrome].
Miki Y
Gan To Kagaku Ryoho; 2017 Feb; 44(2):102-106. PubMed ID: 28223667
[TBL] [Abstract][Full Text] [Related]
19. How to manage BRCA mutation carriers?
Sabiani L; Barrou J; Mathis J; Eisinger F; Bannier M; Lambaudie E; Houvenaeghel G
Horm Mol Biol Clin Investig; 2020 May; 41(3):. PubMed ID: 32459193
[TBL] [Abstract][Full Text] [Related]
20. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
